Sir, Herpes genitalis is the most common sexually transmitted disease worldwide. Its incidence has been increasing, especially among positive human immunodeficiency virus patients. 1 The typical presentations of cutaneous herpes simplex virus are well known and rarely cause diagnostic difficulty. However, in patients with advanced human immunodeficiency virus infection, unusual and severe manifestations of herpes simplex virus infection are common and are included among the opportunistic processes that define the acquired immunodeficiency syndrome. 2 The unusual clinical presentations increasingly observed in clinical practice have led to the use of new treatment modalities such as immunomodulatory agents, in particular topical imiquimod cream as an adjunctive therapy to the first-line drug acyclovir with satisfactory results. 1 Our case report describes a human immunodeficiency virus-infected man with a herpetic infection that was refractory to acyclovir but not to imiquimod, followed by literature review of similar cases.
A 54-year-old human immunodeficiency virus-infected man presented with a 5-month history of painful penile erosions. Physical examination revealed extensive herpetiform erosions involving the penis [ Figure 1a ]. His CD4 cell count was 299/μL and his viral load was undetectable. He had been receiving antiretroviral therapy and had no previous history of genital herpes infection. He had already been treated in a primary health-care unit with acyclovir (4 g daily), penicillin and azithromycin with no improvement. Results of blood tests were positive for syphilis (venereal disease research laboratory 1:32; fluorescent treponemal antibody-absorption positive) and herpes simplex virus (immunoglobulin M negative; immunoglobulin G positive), cytomegalovirus (immunoglobulin M negative; immunoglobulin G positive) and chlamydia (immunoglobulin M negative; immunoglobulin G positive). Skin biopsy was inconclusive. The patient was hospitalized and began empiric treatment with crystalline penicillin and intravenous acyclovir (800 mg three times daily) for 15 days due to oral acyclovir refractory herpes simplex. He was discharged with partially improved but still unhealed genital ulcers.
A second skin biopsy revealed typical herpes inclusions and multinucleated giant cells and immunohistochemical studies supported the diagnosis of herpes simplex virus 1 and 2 infections [ Figure 2a and b]. Subsequently, the patient was treated initially with famciclovir (500 mg two times daily for 8 weeks), but due to high medication cost, it was changed back to acyclovir (400 mg six times daily for 12 weeks). Despite these multiple treatment attempts, he experienced no clinical improvement. The patient was given a trial regimen of topical 5% imiquimod cream applied three times/week for 8 weeks and then five times/week, together with oral acyclovir (400 mg three times daily), for 16 weeks. Complete healing of the lesions was achieved after treatment was completed [ Figure 1b ].
Herpes simplex virus infections are exceedingly common and pose a particular problem in immunocompromised patients. They may experience an excessive number and size of lesions in both primary and reactivated herpes simplex virus infections in comparison with immunocompetent patients. As CD4 cell counts drop and immunosuppression worsens, recurrent episodes increase in frequency and severity until there is no period of complete healing between episodes. Nonhealing ulcers of the genital region in immunocompromised patients should elicit a high degree of Increased dosages of acyclovir, valacyclovir and famciclovir may be required. 3 The emergence of drug-resistant herpesvirus strains is associated with the increase in the use of acyclovir. 4 Foscarnet sodium has been the drug of choice in cases of acyclovir resistance. However, it has also been associated with drug-resistant strains that replicate despite drug presence. 5 Success with topical imiquimod in cases of nonhuman immunodeficiency virus-associated recurrent genital herpes simplex virus infection with documented acyclovir resistance was reported. 6 Topical imiquimod is an immunomodulatory drug that signals through toll-like receptors 7 to stimulate cell-mediated immune responses, showing promising results for the treatment of herpes simplex virus infection and in atypical cases, studies showed that imiquimod provides an added benefit.
1 Therefore, imiquimod presents itself as a valuable ally when treating acyclovir refractory herpes simplex virus infections, particularly in the setting of emerging resistance.
Literature review indicated that despite antiviral resistance, treatment with imiquimod has been successful [ Table 1 ]. Data on 25 patients from 14 different studies showed that clinical cure was the main result with only some instances of recurrences (n = 5) after topical 5% imiquimod therapy.
Our patient failed to respond to classic acyclovir monotherapy, showing a great response after the addition of topical imiquimod cream. Imiquimod may be considered as a possible adjuvant therapy in resistant genital herpes simplex virus infections in light of our experience with this difficult case.
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Nil. Sir, Familial benign chronic pemphigus or Hailey-Hailey disease is a rare autosomal dominant acantholytic disorder clinically characterized by flaccid bullae and erosions in the intertriginous areas, mainly the axillary and inguinal region. We report the unexpected, dramatic and persistent clinical improvement in long-standing cases of Hailey-Hailey disease, with daily intake of a solution containing magnesium chloride.
Case 1: A 34-year-old woman presented with macerated fissured plaques in the axilla and the groin, bilaterally, for 3-4 years with increased severity for the past 2-3 months. She also had a few crusted lesions in the angle of the mouth for 2 months. The cutaneous lesions started as tiny flaccid vesicles on an erythematous base, which ruptured easily and had a tendency to spread peripherally, producing a circinate plaque with crusting and fissures. These lesions were associated with burning sensation and malodor. There were multiple episodes of exacerbation of these lesions, especially in summer. Her mother and brother suffered from similar lesions. The patient had been treated in the past with various oral and topical antibiotics and antifungals, with no response. The general physical examination of the patient revealed erythematous, macerated plaques with multiple fissures and crusts in the axillary and inguinal areas and slight crusting near the angle of mouth [ Figures 1 and 2 ]. Other areas of the skin, mucosal surfaces and nails were normal. All the routine hematological and biochemical investigations were normal. A potassium hydroxide smear for fungal elements was negative, whereas Tzanck smear showed some acantholytic cells. Biopsy taken from the axilla demonstrated intraepidermal acantholysis resulting in a dilapidated brick wall appearance [ Figure 3 ]. Direct immunofluorescence testing was not done. The final diagnosis of Hailey-Hailey disease was made on the basis of history, clinical and histopathological features. The patient was treated with 70 ml of oral magnesium chloride solution containing approximately 300 mg of elemental magnesium, which was prepared by dissolving 33 g of magnesium chloride in 1 L of distilled water. The magnesium solution was taken before breakfast every day. Clotrimazole dusting powder and fusidic acid cream were continued. A significant improvement in the skin lesions was noted after 15 days of treatment and an almost complete remission of signs and symptoms was obtained after 4 weeks [ Figures 4 and 5] . No side effects were reported by the patient, except for the unpleasant taste of the solution. The patient's quality of life significantly improved. The pre-and post-treatment serum levels of electrolytes, in particular, calcium, magnesium and zinc, were within normal limits. The patient is still on treatment for 4 months, with sustained remission. We plan to continue the magnesium chloride solution for 6 months and then taper the dose.
Case 2: The 40-year-old brother of the first patient presented with multiple erosions developing on and off in both axillae for 9 years, with itching and burning sensation [ Figure 6 ]. No other flexural areas were involved. He was taking oral dapsone 100 mg along with topical steroid and antifungal creams for 6 months, with no relief. He was also investigated with a skin biopsy, potassium hydroxide and Tzanck smear. The skin biopsy obtained was consistent with Hailey-Hailey disease. All the routine hematological and biochemical investigations were within normal limits.
He was also treated with 70 ml oral magnesium chloride solution after stopping dapsone and the steroid cream. He responded well within 15 days, with almost complete healing of erosions and did not complain of any adverse effect of magnesium chloride solution. His biochemical parameters after 1 month were within normal limits. The patient is still continuing treatment without any relapse [ Figure 7 ].
Oral magnesium chloride: A novel approach in the management of Hailey-Hailey disease

